Improving Prophylactic Treatment of GBS Positive Patients
Improving Prophylactic Treatment of GBS Positive
PatientsMichelle BlythersLiterature Review PresentationSenior
ProjectOctober 22, 2014
Introduction
A high priority should be placed on identifying Group B
Streptococcus (GBS) positive mothers and the appropriate
administration (>4 hours prior to delivery) of prophylactic
antibiotics.
Importance of Change:
GBS is the leading cause of sepsis, pneumonia and meningitis in
the early newborn period, which is defined a the first week of
life.
Identifying/screening and adequately treating GBS positive
mothers, increases positive patient outcomes.
Article #1 Berardi, A.,Rossi,C.,Biasini, A. Minnitti, S.,
Venturelli, C., Ferrari, Faccinetti, F. (2011) Efficacy of
intrapartum chemoprophylaxis less than 4 hours duration. The
Journal of Maternal-Fetal and neonatal medicine 21(4): 619-625The
data in this article were collected over 12 months, in 2 different
hospitals.This was a quantitative study to compare rate of vertical
transmission of GBS in women with no other risk factors.The
findings were valid.
Article #2 Turrentine, M. Greisinger, A., Brown, K., Wehmanen,
O., Mouzoon, M. (2013). Duration of intrapartum antibiotics for
group b streptococcus on the diagnosis of clinical neonatal sepsis.
Infectious Disease in obstretrics and Gynocology,
1-6.doi:10.1155/2013/525878This particular study was done in a
large facility which delivers over 8,000 infants a year.It was
retrospective cohort study of.The results were that infants whose
mothers received
